JTT-751 for treatment of patients with hyperphosphatemia on peritoneal dialysis
{{output}}
Background/aims: JTT-751 (ferric citrate hydrate) is a novel iron-based phosphate approved in Japan for the treatment of hyperphosphatemia in dialysis and nondialysis patients with chronic kidney disease. ... ...
